140 related articles for article (PubMed ID: 9445254)
1. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2.
Iino M; Foster DC; Kisiel W
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):40-6. PubMed ID: 9445254
[TBL] [Abstract][Full Text] [Related]
2. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
[TBL] [Abstract][Full Text] [Related]
4. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators.
Ameri A; Kuppuswamy MN; Basu S; Bajaj SP
Blood; 1992 Jun; 79(12):3219-26. PubMed ID: 1596565
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
6. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
Rao CN; Mohanam S; Puppala A; Rao JS
Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
[TBL] [Abstract][Full Text] [Related]
8. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
[TBL] [Abstract][Full Text] [Related]
9. Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene.
Kamei S; Kazama Y; Kuijper JL; Foster DC; Kisiel W
Biochim Biophys Acta; 2001 Feb; 1517(3):430-5. PubMed ID: 11342222
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory properties of human recombinant Arg24-->Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2).
Kamei S; Petersen LC; Sprecher CA; Foster DC; Kisiel W
Thromb Res; 1999 May; 94(3):147-52. PubMed ID: 10326761
[TBL] [Abstract][Full Text] [Related]
11. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
13. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
[TBL] [Abstract][Full Text] [Related]
14. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, expression, and characterization of bovine tissue factor pathway inhibitor-2.
Du X; Deng FM; Chand HS; Kisiel W
Arch Biochem Biophys; 2003 Sep; 417(1):96-104. PubMed ID: 12921785
[TBL] [Abstract][Full Text] [Related]
16. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas.
Tasiou A; Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Obeyesekere M; Rao JS
Int J Oncol; 2001 Sep; 19(3):591-7. PubMed ID: 11494041
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.
Sprecher CA; Kisiel W; Mathewes S; Foster DC
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3353-7. PubMed ID: 8159751
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
Petersen LC; Bjørn SE; Olsen OH; Nordfang O; Norris F; Norris K
Eur J Biochem; 1996 Jan; 235(1-2):310-6. PubMed ID: 8631347
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
Grabowski EF; Carter CA; Ingelfinger JR; Tsukurov O; Conroy N; Abbott WM; Orkin RW
Pediatr Res; 1999 Dec; 46(6):742-7. PubMed ID: 10590033
[TBL] [Abstract][Full Text] [Related]
20. Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization.
Udagawa K; Miyagi Y; Hirahara F; Miyagi E; Nagashima Y; Minaguchi H; Misugi K; Yasumitsu H; Miyazaki K
Placenta; 1998; 19(2-3):217-23. PubMed ID: 9548189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]